Safety of Anal Curcumin
Recruiting
Phase 1
Interventional Study
Anal High Grade Squamous Intraepithelial Lesion
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 30 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 48 (estimated)
- Sponsor
- Lisa Flowers · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to see if curcumin can reverse anal high-grade squamous intraepithelial lesions (aHSIL) (high-grade anal precancerous cells or high-grade abnormal cells) in people living with HIV to avoid current treatments such as ablation (destroying abnormal cells with heat or surgical excision (cutting out the abnormal cells)), which have potential short- and long-term side effect…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Major Inclusion Criteria:
* 30 and older
* Have biopsy-proven anal intraepithelial neoplasia (AIN) 2, AIN 3 without previous treatment
* Or cytology results for ASC-H or HSIL
* Able and willing to complete Study Diary
* Other inclusion criteria apply
Exclusion Criteria:
* Have a clinically signif…
Contacts